Inventiva Strengthens Balance Sheet With $172.5M Offering; Eyes Mid-2027 Cash Runway
Inventiva raises $172.5M, strengthening balance sheet to €230.9M in liquidity. Clinical-stage biotech projects cash runway through mid-2027 to advance MASH treatment program.
IVApublic offeringclinical-stage biopharmaceutical